Medline Inc. (MDLN)
Medline Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Medline Inc. (MDLN) is a Medical - Instruments & Supplies company based in US with a market capitalization of $31.2B. Revenue grew 11.5% year-over-year and the company generated $1.7B in free cash flow. This page tracks MDLN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 43K employees · IPO Dec 17, 2025
Valuation
Valuation & price
$36.19 · as of May 17, 2026 · -27.6% vs 52w high
25.4
P/E ratio
Latest-FY diluted EPS
2.90
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$31.2B
Market cap
11.5%
Revenue growth (YoY)
26.4%
Gross margin
$1.7B
Free cash flow (USD)
$10.6B
Net debt
3.2%
Share dilution
1/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2022 → 2025
Free cash flow by year
2022 → 2025
Gross margin by year
2022 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 6, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Medline Inc.'s market cap?
Medline Inc. (MDLN) has a market capitalization of $31.2B.
What is MDLN's P/E ratio?
MDLN trades at a price-to-earnings ratio of 25.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is MDLN's price-to-book (P/B) ratio?
MDLN trades at 2.90 times book value per share.
Are insiders buying MDLN stock?
SEC Form 4 filings show no open-market insider buys at Medline Inc. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Instruments & Supplies
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.